Literature DB >> 16647641

The effect of hypoxia on lipid phosphate receptor and sphingosine kinase expression and mitogen-activated protein kinase signaling in human pulmonary smooth muscle cells.

Maqsood Ahmad1, Jaclyn S Long, Nigel J Pyne, Susan Pyne.   

Abstract

Both acute and chronic hypoxia had no effect on S1P(1), S1P(3) or LPA(1) receptor transcript expression in human pulmonary smooth muscle cells. However, acute hypoxia increased sphingosine kinase SK1/2 and LPP1 mRNA transcript levels, while chronic hypoxia increased SK1 mRNA transcript alone. Acute hypoxia had no effect on S1P-, PDGF- or phorbol ester (PMA)-stimulated activation of ERK-1/2, but increased the ability of S1P to activate p38 MAPK. Chronic hypoxia increased the ability of S1P to stimulate the phosphorylation of ERK-1/2. Therefore, we have demonstrated for the first time that hypoxia can lead to marked changes in the expression of genes involved in S1P production and may modify post S1P receptor signal transduction pathways.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16647641     DOI: 10.1016/j.prostaglandins.2006.03.001

Source DB:  PubMed          Journal:  Prostaglandins Other Lipid Mediat        ISSN: 1098-8823            Impact factor:   3.072


  19 in total

1.  The sphingosine kinase 1 inhibitor 2-(p-hydroxyanilino)-4-(p-chlorophenyl)thiazole induces proteasomal degradation of sphingosine kinase 1 in mammalian cells.

Authors:  Carolyn Loveridge; Francesca Tonelli; Tamara Leclercq; Keng Gat Lim; Jaclyn S Long; Evgeny Berdyshev; Rothwelle J Tate; Viswanathan Natarajan; Stuart M Pitson; Nigel J Pyne; Susan Pyne
Journal:  J Biol Chem       Date:  2010-10-06       Impact factor: 5.157

2.  Development of amidine-based sphingosine kinase 1 nanomolar inhibitors and reduction of sphingosine 1-phosphate in human leukemia cells.

Authors:  Andrew J Kennedy; Thomas P Mathews; Yugesh Kharel; Saundra D Field; Morgan L Moyer; James E East; Joseph D Houck; Kevin R Lynch; Timothy L Macdonald
Journal:  J Med Chem       Date:  2011-05-02       Impact factor: 7.446

3.  Sphingosine kinase-2 inhibition improves mitochondrial function and survival after hepatic ischemia-reperfusion.

Authors:  Yanjun Shi; Hasibur Rehman; Venkat K Ramshesh; Justin Schwartz; Qinlong Liu; Yasodha Krishnasamy; Xun Zhang; John J Lemasters; Charles D Smith; Zhi Zhong
Journal:  J Hepatol       Date:  2011-07-12       Impact factor: 25.083

4.  Novel sphingosine-containing analogues selectively inhibit sphingosine kinase (SK) isozymes, induce SK1 proteasomal degradation and reduce DNA synthesis in human pulmonary arterial smooth muscle cells.

Authors:  Hoe-Sup Byun; Susan Pyne; Neil Macritchie; Nigel J Pyne; Robert Bittman
Journal:  Medchemcomm       Date:  2013       Impact factor: 3.597

5.  Inhibition of sphingosine kinase 2 downregulates the expression of c-Myc and Mcl-1 and induces apoptosis in multiple myeloma.

Authors:  Jagadish Kummetha Venkata; Ningfei An; Robert Stuart; Luciano J Costa; Houjian Cai; Woodrow Coker; Jin H Song; Kiwana Gibbs; Terri Matson; Elizabeth Garrett-Mayer; Zhuang Wan; Besim Ogretmen; Charles Smith; Yubin Kang
Journal:  Blood       Date:  2014-09-18       Impact factor: 22.113

6.  S1P2 receptor-dependent Rho-kinase activation mediates vasoconstriction in the murine pulmonary circulation induced by sphingosine 1-phosphate.

Authors:  William S Szczepaniak; Bruce R Pitt; Bryan J McVerry
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-04-30       Impact factor: 5.464

7.  The sphingosine kinase 1/sphingosine-1-phosphate pathway in pulmonary arterial hypertension.

Authors:  Jiwang Chen; Haiyang Tang; Justin R Sysol; Liliana Moreno-Vinasco; Krystyna M Shioura; Tianji Chen; Irina Gorshkova; Lichun Wang; Long Shuang Huang; Peter V Usatyuk; Saad Sammani; Guofei Zhou; J Usha Raj; Joe G N Garcia; Evgeny Berdyshev; Jason X-J Yuan; Viswanathan Natarajan; Roberto F Machado
Journal:  Am J Respir Crit Care Med       Date:  2014-11-01       Impact factor: 21.405

8.  Regulation of cancer cell migration and invasion by sphingosine-1-phosphate.

Authors:  James R Van Brocklyn
Journal:  World J Biol Chem       Date:  2010-10-26

Review 9.  Sphingosine 1-phosphate and cancer.

Authors:  Nigel J Pyne; Susan Pyne
Journal:  Nat Rev Cancer       Date:  2010-06-17       Impact factor: 60.716

10.  Full pharmacological efficacy of a novel S1P1 agonist that does not require S1P-like headgroup interactions.

Authors:  Pedro J Gonzalez-Cabrera; Euijung Jo; M Germana Sanna; Steven Brown; Nora Leaf; David Marsolais; Marie-Therese Schaeffer; Jacqueline Chapman; Michael Cameron; Miguel Guerrero; Edward Roberts; Hugh Rosen
Journal:  Mol Pharmacol       Date:  2008-08-15       Impact factor: 4.436

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.